43 research outputs found

    Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The effects of gonadotrophin-releasing hormone agonist (GnRH-a) administered in the luteal phase remains controversial. This meta-analysis aimed to evaluate the effect of the administration of a single-dose of GnRH-a in the luteal phase on ICSI clinical outcomes.</p> <p>Methods</p> <p>The research strategy included the online search of databases. Only randomized studies were included. The outcomes analyzed were implantation rate, clinical pregnancy rate (CPR) per transfer and ongoing pregnancy rate. The fixed effects model was used for odds ratio. In all trials, a single dose of GnRH-a was administered at day 5/6 after ICSI procedures.</p> <p>Results</p> <p>All cycles presented statistically significantly higher rates of implantation (P < 0.0001), CPR per transfer (P = 0.006) and ongoing pregnancy (P = 0.02) in the group that received luteal-phase GnRH-a administration than in the control group (without luteal-phase-GnRH-a administration). When meta-analysis was carried out only in trials that had used long GnRH-a ovarian stimulation protocol, CPR per transfer (P = 0.06) and ongoing pregnancy (P = 0.23) rates were not significantly different between the groups, but implantation rate was significant higher (P = 0.02) in the group that received luteal-phase-GnRH-a administration. On the other hand, the results from trials that had used GnRH antagonist multi-dose ovarian stimulation protocol showed statistically significantly higher implantation (P = 0.0002), CPR per transfer (P = 0.04) and ongoing pregnancy rate (P = 0.04) in the luteal-phase-GnRH-a administration group. The majority of the results presented heterogeneity.</p> <p>Conclusions</p> <p>These findings demonstrate that the luteal-phase single-dose GnRH-a administration can increase implantation rate in all cycles and CPR per transfer and ongoing pregnancy rate in cycles with GnRH antagonist ovarian stimulation protocol. Nevertheless, by considering the heterogeneity between the trials, it seems premature to recommend the use of GnRH-a in the luteal phase. Additional randomized controlled trials are necessary before evidence-based recommendations can be provided.</p

    Approaches to improve the diagnosis and management of infertility

    Get PDF
    Recent advances in our understanding of the causes of infertility and of assisted reproductive technology (ART) have led to the development of complex diagnostic tools, prognostic models and treatment options. The Third Evian Annual Reproduction (EVAR) Workshop Meeting was held on 26-27 April 2008 to evaluate evidence supporting current approaches to the diagnosis and management of infertility and to identify areas for future research efforts. Specialist reproductive medicine clinicians and scientists delivered presentations based on published literature and ongoing research on patient work-up, ovarian stimulation and embryo quality assessment during ART. This report is based on the expert presentations and subsequent group discussions and was supplemented with publications from literature searches and the authors' knowledge. It was agreed that single embryo transfer (SET) should be used with increasing frequency in cycles of ART. Continued improvements in cryopreservation techniques, which improve pregnancy rates using supernumerary frozen embryos, are expected to augment the global uptake of SET. Adaptation and personalization of fertility therapy may help to optimize efficacy and safety outcomes for individual patients. Prognostic modelling and personalized management strategies based on individual patient characteristics may prove to represent real progress towards improved treatment. However, at present, there is limited good-quality evidence to support the use of these individualized approaches. Greater quality control and standardization of clinical and laboratory evaluations are required to optimize ART practices and improve individual patient outcomes. Well-designed, good-quality studies are required to drive improvements to the diagnosis and management of ART processes

    116 EXPERIENCE OF A CROSS BORDER DONOR EGG IVF PROGRAM

    Full text link

    The impact of endometrial polyps on assisted reproductive treatment outcome

    Full text link

    Development of Children

    No full text
    Purpose: The numbers of early childhood education programs are dramatically increasing throughout Turkey, and the regulations to ensure quality are frequently changing. A very limited number of studies have examined the quality of Turkish ECE programs on children's development. Therefore, the purpose of this study is to identify the effects of classroom size and duration on the development of children.Research Methods: This is a relational survey study that was realized with 836 children attending 55 public early childhood programs in Denizli. These children were selected through a cluster sampling method. Data were collected through the "Ankara Developmental Screening Inventory" and "Informational questionnaire." Data were analyzed using repeated ANOVAs, factorial ANOVA (2X4) and independent t-test techniques.Findings: This research revealed that there were statistically significant interactions between children's development and the structural quality components of classroom size and duration of education. Our findings showed that classrooms containing 20 to 24 children had higher developmental scores than other groups. Additionally, the results indicated that children enrolled in full-day programs scored higher on the language and cognitive development subscale and total ADSI.Implications for Research and Practice: The findings revealed that the children attending full-day programs with classroom sizes averaging 20 to 24 differed significantly from the children in other groups. This suggests that full-day programs have positive effects on children's development; therefore, it is important to increase the number of full-day programs in Turkey. (C) 2017 Ani Publishing Ltd. All rights reserve

    Plexiform neurofibroma during and after pregnancy.

    No full text
    corecore